This announcement is a separate document:
富祥药业：2023年度以简易程序向特定对象发行股票募集资金使用可行性分析报告（修订稿）
Fuxiang Pharmaceutical: Feasibility Analysis Report on the Use of Funds Raised by Issuing Shares to Specific Targets with Simple Procedures in 2023 (Revised Draft)
The translation is provided by third-party software.
The above content is for informational or educational purposes only and does not constitute any investment advice related to Futu. Although we strive to ensure the truthfulness, accuracy, and originality of all such content, we cannot guarantee it.